Medications

Medications for oral cancer encompass a range of therapeutic options tailored to target cancer cells and manage symptoms. Conventional treatments include chemotherapy drugs like cisplatin and carboplatin, which aim to kill cancer cells or inhibit their growth. Targeted therapies, such as tyrosine kinase inhibitors (e.g., cetuximab), focus on specific molecular targets associated with cancer progression. Immunotherapy, including checkpoint inhibitors (e.g., pembrolizumab), helps the immune system recognize and attack cancer cells more effectively. Additionally, hormonal therapies and pain management medications play crucial roles in addressing cancer-related symptoms and improving the quality of life. These medications are often used in combination to enhance efficacy and tailor treatment to individual patient needs.

    Related Conference of Medications

    September 16-17, 2024

    9th World Conference on Breast and Cervical Cancer

    London, UK
    September 19-20, 2024

    25th World Congress on Cancer Summit

    Paris, France
    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    44th Euro Congress on Cancer Science & Therapy

    Paris, France
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK

    Medications Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in